JUAN
SANCHIS FORES
CATEDRÁTICO/A DE UNIVERSIDAD
Hospital Universitario Virgen de las Nieves
Granada, EspañaPublications in collaboration with researchers from Hospital Universitario Virgen de las Nieves (12)
2022
-
Temporal trend and potential impact of angiotensin receptor neprilysin inhibitors on transcatheter edge-to-edge mitral valve repair
Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1001-1010
2021
-
Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation
International Journal of Cardiology, Vol. 345, pp. 29-35
2020
-
Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: A real-life propensity-score matched study
Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-14
2019
-
Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary Angioplasty
Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1005-1011
-
Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry
Revista Espanola de Cardiologia, Vol. 72, Núm. 5, pp. 373-382
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
-
Multivessel disease in patients over 75 years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI + 75 nation-wide registry
Cardiovascular Revascularization Medicine, Vol. 19, Núm. 5, pp. 580-588
2017
-
Angioplastia primaria en mayores de 75 años. Perfil de pacientes y procedimientos, resultados y predictores pronósticos en el registro ESTROFA IM + 75
Revista Espanola de Cardiologia, Vol. 70, Núm. 2, pp. 81-87
-
Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)
American Journal of Cardiology, Vol. 119, Núm. 7, pp. 983-990
2016
-
Everolimus-eluting stents in patients with bare-metal and drug-eluting in-stent restenosis
Circulation: Cardiovascular Interventions, Vol. 9, Núm. 7
2015
-
Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2
Revista Espanola de Cardiologia, Vol. 68, Núm. 10, pp. 838-845
2014
-
A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)
Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386